Zimmer Biomet Aktie
| 105,75USD | 0,94USD | 0,90% |
WKN: 753718 / ISIN: US98956P1021
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99,86 |
| The Vanguard Group, Inc. | 11,60 |
| Vanguard Group, Inc. (Subfiler) | 10,94 |
| Dodge & Cox | 8,14 |
| T Rowe Price Associates, Inc. (13F Subfiler) | 5,89 |
| Dodge & Cox | 5,58 |
| Dodge & Cox Stock Fund | 5,29 |
| T. Rowe Price Associates, Inc. (Investment Management) | 4,58 |
| State Street Corp. | 4,48 |
| BlackRock Fund Advisors | 3,44 |
| Vanguard Total Stock Market ETF | 3,16 |
| American Century Cos., Inc. | 3,14 |
| Vanguard 500 Index Fund | 2,60 |
| PRIMECAP Management Co. | 2,46 |
| Capital Research & Management Co. (International Investors) | 2,43 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 19 900 | 20 000 | 19 500 | 18 000 | 18 000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,40 | 0,35 | 0,40 | 0,39 | 0,41 |
Bilanz (in Mio. USD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 4 724 | 5 083 | 4 885 | 4 427 | 4 610 |
| Summe Anlagevermögen | 20 889 | 20 614 | 20 019 | 17 937 | 18 476 |
| Summe Aktiva | 24 639 | 24 418 | 23 456 | 21 066 | 21 497 |
Bilanz (in Mio. USD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 8 501 | 8 419 | 7 358 | 5 917 | 5 995 |
| Summe Fremdkapital | 12 246 | 12 218 | 10 790 | 9 039 | 9 009 |
| Summe Eigenkapital | 12 393 | 12 199 | 12 666 | 12 027 | 12 488 |
| Summe Passiva | 24 639 | 24 418 | 23 456 | 21 066 | 21 497 |
Adresse
| 345 East Main Street, 46580 Warsaw | |
| Telefon | +1 (574) 373-3333 |
| Internet | http://www.zimmerbiomet.com |
Management
|
Angela Main
Chief Compliance Officer & Senior Vice President |
|
Arthur Joseph Higgins
Independent Director |
|
Betsy J. Bernard
Independent Director |
|
Chad F. Phipps
Secretary, Senior Vice President & General Counsel |
|
Christopher B. Begley
Chairman |
|
David J. Kunz
Senior VP-Global Quality & Regulatory Affairs |
|
Derek M. Davis
Vice President-Finance Integration |
|
Devdatt Kurdikar
Director |
|
Ivan Tornos
President, Chief Executive Officer & Director |
|
Jiny Kim
VP-Smart Implants, Technology & Data Solutions |
|
Josh Edmonds
Sales Representative |
|
Kenneth R. Tripp
Senior VP-Global Operations & Logistics |
|
Keri P. Mattox
Chief Communications & Administrative Officer |
|
Lori Winkler
Chief Human Resources Officer & Senior VP |
|
Louis A. Shapiro
Independent Director |
|
Maria Teresa Hilado
Independent Director |
|
Michael J. Farrell
Independent Director |
|
Nitin Goyal
Chief Science, Technology & Innovation Officer |
|
Paul Stellato
Chief Accounting Officer, VP & Controller |
|
Rachel H. Ellingson
Chief Strategy Officer & Senior Vice President |
|
Richard J. Heppenstall
Chief Financial Officer-Newco |
|
Robert A. Hagemann
Independent Director |
|
Sang Yi
Group President-Asia Pacific |
|
Sreelakshmi Kolli
Independent Director |
|
Suketu P. Upadhyay
CFO, EVP-Finance, Operations & Supply Chain |
|
Syed A. Jafry
Independent Director |
|
Wilfred van Zuilen
Group President-EMEA |
|
Zach Weiner
Director-Investor Relations |
|
Zeeshan Tariq
Chief Information Officer & Senior Vice President |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
